<--- Back to Details
| First Page | Document Content | |
|---|---|---|
 Date: 2010-03-31 20:47:16TiHKAL C11H14N2 Tryptamine Designer drug N-Methyltryptamine Alpha-Methyltryptamine Gas chromatography–mass spectrometry Substituted amphetamine C12H16N2 Chemistry Monoamine oxidase inhibitors 5-MeO-AMT |
| 4 PHARMACOLOGIC TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) IN ADULTSDocID: 1r9hg - View Document |
| Exhibit 1: Public plan listings in Canada for stimulants and non-stimulants for treatment of ADHD Drug Brand nameDocID: 1pZTJ - View Document |
| the side effects of common psychiatric drugs A report by the citizens commission on human rights® international Mission StatementDocID: 1puhm - View Document |
| Trxuth About Prescription Stimulant Abuse go.osu.edu/generationrxDocID: 1ptQB - View Document |
| Trxuth About Prescription Stimulant Abuse Script with Discussion Questions & Notes Narrator: The National Council on Patient Information and Education1 tells us the following: by a student’s sophomore year in collegeDocID: 1pjAj - View Document |